Literature DB >> 22104148

Synthesis, antitubercular evaluation and 3D-QSAR study of N-phenyl-3-(4-fluorophenyl)-4-substituted pyrazole derivatives.

R C Khunt1, V M Khedkar, R S Chawda, N A Chauhan, A R Parikh, E C Coutinho.   

Abstract

As a part of our ongoing research to develop novel antitubercular agents, a series of N-phenyl-3-(4-fluorophenyl)-4-substituted pyrazoles have been synthesized and tested for antimycobacterial activity in vitro against Mycobacterium tuberculosis H37Rv strain using the BACTEC 460 radiometric system. A 3D-QSAR study based on CoMFA and CoMSIA was performed on these pyrazole derivatives to correlate their chemical structures with the observed activity against M. tuberculosis. The CoMFA model provided a significant correlation of steric and electrostatic fields with the biological activity while the CoMSIA model could additionally shed light on the role of hydrogen bonding and hydrophobic features. The important features identified in the 3D-QSAR models have been used to propose new molecules whose activities are predicted higher than the existing systems. This study provides valuable directions to our ongoing endeavor of rationally designing more potent antitubercular agents.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22104148     DOI: 10.1016/j.bmcl.2011.10.059

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

Review 1.  Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review.

Authors:  Khalid Karrouchi; Smaail Radi; Youssef Ramli; Jamal Taoufik; Yahia N Mabkhot; Faiz A Al-Aizari; M'hammed Ansar
Journal:  Molecules       Date:  2018-01-12       Impact factor: 4.411

2.  QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity.

Authors:  Marcelo N Gomes; Rodolpho C Braga; Edyta M Grzelak; Bruno J Neves; Eugene Muratov; Rui Ma; Larry L Klein; Sanghyun Cho; Guilherme R Oliveira; Scott G Franzblau; Carolina Horta Andrade
Journal:  Eur J Med Chem       Date:  2017-05-10       Impact factor: 6.514

3.  Antibacterial evaluation and molecular docking studies of pyrazole-thiosemicarbazones and their pyrazole-thiazolidinone conjugates.

Authors:  Oluwakemi Ebenezer; Ashona Singh-Pillay; Neil A Koorbanally; Parvesh Singh
Journal:  Mol Divers       Date:  2020-02-21       Impact factor: 2.943

4.  Novel piperazine-chalcone hybrids and related pyrazoline analogues targeting VEGFR-2 kinase; design, synthesis, molecular docking studies, and anticancer evaluation.

Authors:  Marwa F Ahmed; Eman Y Santali; Radwan El-Haggar
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.